Improvement in minutes, 6 years after stroke, following perispinal etanercept treatment by Edward Tobinick M.D. on January 3, 2019. Treatment at the Institute of Neurological Recovery in Boca Raton, FL. 4K version with subtitles. Text, images and video © 2019, INR PLLC, all rights reserved.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Rapid neurological improvement 2.5 years after brain injury due to cardiac arrest following perispinal etanercept treatment. Treatment by Edward Tobinick M.D. at the INR in Boca Raton, Florida. Filmed December 6, 2018, 4K version with subtitles. Text, images and video © 2019, INR PLLC, all rights reserved.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Many rapid improvements 18 years after stroke. Treatment by Edward Tobinick M.D. at the INR in Boca Raton, Florida. Filmed November 29, 2018, 4K version, with subtitles. Text, images and video © 2018, INR PLLC, all rights reserved.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Immediate improvement in chronic post-stroke pain 2 years after stroke. Treatment by Edward Tobinick, filmed November 20, 2018, at the INR in Boca Raton. 4K version, with subtitles. Text, images and video © 2018, INR PLLC, all rights reserved.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Immediate improvement in central post-stroke pain, 3 years after stroke, following perispinal etanercept. Treatment and filming Oct 31, 2018 and Nov 7, 2018, INR Boca Raton. 4K version, with subtitles. Text, images and video © 2018, INR PLLC, all rights reserved.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
From Iceland, A Message of Hope. Perispinal Etanercept Treatment by Edward Tobinick M.D. at the INR Boca Raton enables return to work after stroke. Text, images and video © 2018, INR PLLC, all rights reserved.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
News Release, October 8, 2018: The Australian Government will invest $1 million to improve recovery and rehabilitation and help stroke survivors back to work. The Government package includes $750,000 specifically designated for funding a clinical trial of the innovative Perispinal Etanercept Stroke Treatment in Australia. “The project will enable more Australians of working age who have had a stroke to access new innovative and cutting edge treatment options to aid their recovery.”
Perispinal etanercept for treatment of chronic post-stroke neurological dysfunction is a treatment method invented and developed by Edward Tobinick M.D., Medical Director and Founder of the Institute of Neurological Recovery.
More at this link: http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2018-hunt134.htm
Immediate neurological recovery after treatment at the Institute of Neurological Recovery, September 14, 2018, two years after stroke. Improvements noted in speech, aphasia, apraxia and walking within minutes after treatment at the INR in Boca Raton, Florida.
Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
From Kentucky to the INR in Boca Raton, Florida. Published July 16, 2018.
Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Invited editorial by Edward Tobinick, MD, entitled, “Perispinal etanercept advances as a neurotherapeutic” published in Expert Review of Neurotherapeutics, on April 25, 2018.